Aptinyx Inc. (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 10, 2016
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $65,000,000
Company Info
- Founders
- Norbert G. Riedel, Ph.D.
- Company Description
- Aptinyx Inc. is a biopharmaceutical company focused on discovery and development of transformative therapies for challenging neurological disorders. Aptinyx has a proven platform for discovering compounds that enhance synaptic plasticity, or strengthen the network for neural cell communication.
- Market
- Neurological disorders
- Location
- Evanston, Illinois, USA
- Coinvestors
- Adams Street Partners, Beecken Petty O'Keefe & Company, Frazier Healthcare, Goudy Park Capital, Longitude Capital, LVP Life Sciences Ventures, New Leaf Venture Partners, Northwestern University, Osage University Partners, PathoCapital